Advisory Committee Vacancies Remain High As FDA Revs Up Search
This article was originally published in The Tan Sheet
Executive Summary
With its recent hiring push drawing attention, FDA is quietly undertaking another recruitment effort - filling advisory committee roster vacancies
You may also be interested in...
FDA Advisory Committees Would Get Patient Influence Under Hagan Bill
Adjusting advisory committee conflict of interest rules becomes a high-priority issue in reauthorizing FDA’s drug user fee program. With several bills proposing to loosen the rules, Sen. Hagan’s draft FDA reform legislation could bring the most changes.
FDA Advisory Committees Would Get Patient Influence Under Hagan Bill
Adjusting advisory committee conflict of interest rules becomes a high-priority issue in reauthorizing FDA’s drug user fee program. With several bills proposing to loosen the rules, Sen. Hagan’s draft FDA reform legislation could bring the most changes.
FDA Works To Fill Advisory Panel Seats While Tightening Conflict Rules
FDA is working on an initiative to bring current advisory committee vacancies from around 30 percent down to 10 percent of its more than 600 spots without backing down from a strict conflict-of-interest policy that many see as contributing to the difficulty in filling the seats